1953
DOI: 10.1097/00000658-195304000-00024
|View full text |Cite
|
Sign up to set email alerts
|

Repair of Surgical Abdominal Wall Defect With a Pedicled Musculofascial Flap

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

1957
1957
2017
2017

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(4 citation statements)
references
References 2 publications
0
4
0
Order By: Relevance
“…Such a prosthesis would be (1) chemically inert, (2) noncarcinogenic, (3) resistant to mechanical strain, (4) sterilizable, (5) unmodified by tissue fluids, (6) hypoallergenic, (7) noninflammatory, (8) con¬ formable to different shapes, and (9) nonrigid.9 A host of materials have been tested, including Dacron-reinforced silicon rubber (Silastic),9,10 preserved human dura,10 nylon woven mesh,9 polyester fiber mesh (Mersilene),11 braided carbon fiber," stainless-steel mesh,9 polytetrafluoroethyl¬ ene (Goretex),10,12 and polypropylene mesh (Marlex). 10,12,13 Probably because of its strength and low reactivity, poly¬ propylene mesh has emerged as the prosthetic agent of choice in repairing both clean and contaminated abdominalwall defects.…”
Section: Commentmentioning
confidence: 99%
“…Such a prosthesis would be (1) chemically inert, (2) noncarcinogenic, (3) resistant to mechanical strain, (4) sterilizable, (5) unmodified by tissue fluids, (6) hypoallergenic, (7) noninflammatory, (8) con¬ formable to different shapes, and (9) nonrigid.9 A host of materials have been tested, including Dacron-reinforced silicon rubber (Silastic),9,10 preserved human dura,10 nylon woven mesh,9 polyester fiber mesh (Mersilene),11 braided carbon fiber," stainless-steel mesh,9 polytetrafluoroethyl¬ ene (Goretex),10,12 and polypropylene mesh (Marlex). 10,12,13 Probably because of its strength and low reactivity, poly¬ propylene mesh has emerged as the prosthetic agent of choice in repairing both clean and contaminated abdominalwall defects.…”
Section: Commentmentioning
confidence: 99%
“…Lesnick and Davids first used the EOMCF for closure of lower abdominal wall defects in 1952 . Since its introduction, the EOMCF has been used successfully for coverage of upper abdominal, pelvic, and chest‐wall defects, including those caused by advanced breast cancer .…”
Section: Discussionmentioning
confidence: 99%
“…Although initially described as a myofascial flap for abdominal reconstruction, the external oblique flap subsequently has been more commonly used as a myocutaneous flap for repair of the chest wall. 47 The external oblique flap territory is large, extending from the midline of the abdomen to the anterior axillary line. The flap is elevated medially and rotated superiorly into the defect.…”
Section: External Oblique Flapsmentioning
confidence: 99%